Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels

Molecular Therapy

Volumn 18, Issue 4, 2010, Pages 700-706

  Shin, Seungjin ^a   Shea, Lonnie D ^a,b  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; COLLAGEN; HYDROXYAPATITE; LENTIVIRUS VECTOR; NANOPARTICLE;

ARTICLE; BIOLUMINESCENCE; CELL STRAIN HEK293; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO GENE TRANSFER; IN VIVO STUDY; LENTIVIRINAE; NONHUMAN; REGENERATIVE MEDICINE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; BIOCOMPATIBLE MATERIALS; DURAPATITE; GENE THERAPY; GENETIC VECTORS; HYDROGEL; LENTIVIRUS; MALE; MICE; NANOPARTICLES;

LENTIVIRUS;

EID: 77950518688     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.300     Document Type: Article

References (31)

1. Bonadio, J, Smiley, E, Patil, P and Goldstein, S (1999). Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5: 753-759. (Pubitemid 29318608)
2. Sakiyama-Elbert, SE, Panitch, A and Hubbell, JA (2001). Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J 15: 1300-1302.
3. Stendahl, JC, Wang, LJ, Chow, LW, Kaufman, DB and Stupp, SI (2008). Growth factor delivery from self-assembling nanofbers to facilitate islet transplantation. Transplantation 86: 478-481.
4. Xu, M, Kreeger, PK, Shea, LD and Woodruff, TK (2006). Tissue-engineered follicles produce live, fertile offspring. Tissue Eng 12: 2739-2746. (Pubitemid 46141242)
5. Langer, R and Tirrell, DA (2004). Designing materials for biology and medicine. Nature 428: 487-492. (Pubitemid 38480528)
6. Anseth, KS, Bowman, CN and Brannon-Peppas, L (1996). Mechanical properties of hydrogels and their experimental determination. Biomaterials 17: 1647-1657. (Pubitemid 26278972)
7. Segura, T, Anderson, BC, Chung, PH, Webber, RE, Shull, KR and Shea, LD (2005). Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials 26: 359-371. (Pubitemid 38951103)
8. Hartgerink, JD, Beniash, E and Stupp, SI (2002). Peptide-amphiphile nanofbers: a versatile scaffold for the preparation of self-assembling materials. Proc Natl Acad Sci USA 99: 5133-5138. (Pubitemid 34411515)
9. Lutolf, M P, Tirelli, N, Cerritelli, S, Cavalli, L and Hubbell, JA (2001). Systematic modulation of Michael-type reactivity of thiols through the use of charged amino acids. Bioconjug Chem 12: 1051-1056. (Pubitemid 33136878)
10. Salvay, DM and Shea, LD (2006). Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol Biosyst 2: 36-48.
11. Doukas, J, Blease, K, Craig, D, Ma, C, Chandler, LA, Sosnowski, BA et al. (2002). Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle. Mol Ther 5(5 Pt 1): 517-527. (Pubitemid 34546081)
12. Levy, RJ, Song, C, Tallapragada, S, DeFelice, S, Hinson, JT, Vyavahare, N et al. (2001). Localized adenovirus gene delivery using antiviral IgG complexation. Gene Ther 8: 659-667. (Pubitemid 32496428)
13. Hu, WW, Wang, Z, Hollister, SJ and Krebsbach, PH (2007). Localized viral vector delivery to enhance in situ regenerative gene therapy. Gene Ther 14: 891-901. (Pubitemid 46780072)
14. Croyle, MA, Roessler, BJ, Davidson, BL, Hilfnger, JM and Amidon, GL (1998). Factors that infuence stability of recombinant adenoviral preparations for human gene therapy. Pharm Dev Technol 3: 373-383.
15. Schek, RM, Hollister, SJ and Krebsbach, PH (2004). Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol Ther 9: 130-138.
16. Higashikawa, F and Chang, L (2001). Kinetic analyses of stability of simple and complex retroviral vectors. Virology 280: 124-131. (Pubitemid 34158058)
17. Sato, H, Takino, T, Okada, Y, Cao, J, Shinagawa, A, Yamamoto, E et al. (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65. (Pubitemid 24216953)
18. Beliën, AT, Paganetti, PA and Schwab, ME (1999). Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J Cell Biol 144: 373-384.
19. Watanabe, K, Nakamura, M, Okano, H and Toyama, Y (2007). Establishment of three-dimensional culture of neural stem/progenitor cells in collagen Type-1 Gel. Restor Neurol Neurosci 25: 109-117. (Pubitemid 47290438)
20. Fang, J, Zhu, YY, Smiley, E, Bonadio, J, Rouleau, JP, Goldstein, SA et al. (1996). Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 93: 5753-5758. (Pubitemid 26190752)
21. Scherer, F, Schillinger, U, Putz, U, Stemberger, A and Plank, C (2002). Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo. J Gene Med 4: 634-643. (Pubitemid 40277187)
22. Premaraj, S, Mundy, BL, Morgan, D, Winnard, PL, Mooney, MP and Moursi, AM (2006). Sustained delivery of bioactive cytokine using a dense collagen gel vehicle collagen gel delivery of bioactive cytokine. Arch Oral Biol 51: 325-333. (Pubitemid 43363508)
23. Shin, S, Salvay, DM and Shea, LD (2009). Lentivirus delivery by adsorption to tissue engineering scaffolds. J Biomed Mater Res A (epub ahead of print).
24. Chandler, LA, Doukas, J, Gonzalez, AM, Hoganson, DK, Gu, DL, Ma, C et al. (2000). FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. Mol Ther 2: 153-160.
25. Doukas, J, Chandler, LA, Gonzalez, AM, Gu, D, Hoganson, DK, Ma, C et al. (2001). Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum Gene Ther 12: 783-798. (Pubitemid 32692344)
26. Ochiya, T, Nagahara, S, Sano, A, Itoh, H and Terada, M (2001). Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines. Curr Gene Ther 1: 31-52.
27. Tyrone, JW, Marcus, JR, Bonomo, SR, Mogford, JE, Xia, Y and Mustoe, TA (2000). Transforming growth factor beta3 promotes fascial wound healing in a new animal model. Arch Surg 135: 1154-1159.
28. Berry, M, Gonzalez, AM, Clarke, W, Greenlees, L, Barrett, L, Tsang, W et al. (2001). Sustained effects of gene-activated matrices after CNS injury. Mol Cell Neurosci 17: 706-716. (Pubitemid 32430046)
29. Schlegel, R, Tralka, TS, Willingham, MC and Pastan, I (1983). Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 32: 639-646.
30. Zaman, MH, Kamm, RD, Matsudaira, P and Lauffenburger, DA (2005). Computational model for cell migration in three-dimensional matrices. Biophys J 89: 1389-1397. (Pubitemid 41099020)
31. Zaman, MH, Trapani, LM, Sieminski, AL, Siemeski, A, Mackellar, D, Gong, H et al. (2006). Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci USA 103: 10889-10894. (Pubitemid 44148391)